In Depth Research on India Cervical Cancer Screening Market Outlook 2022

Cervical cancer is an important area of action for any cancer control programme because of the burden of disease, and the potential for effective prevention through screening. Cervical cancer hardly presents any symptoms in its early stages and it highlights the importance of regular screening for the disease. Screening is looking for cancer before a person has any symptoms. This can help to find the cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat.

Screening programs involve the testing of asymptomatic individuals with a precise screening test to identify those who likely to have the disease of interest and for the further investigation to confirm or exclude the disease. The aim of cancer screening is to prevent the cancer deaths and to improve the quality of life by finding cancers in early stage and by effectively treating them.

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-india-cervical-cancer-screening-market-outlook-2022.php

Table of contents

Overview of the Cervical Cancer
1.1 Introduction
1.2 Stages of the Cervical Cancer
1.2.1 Stage 0
1.2.2 Stage 1
1.2.3 Stage 2
1.2.4 Stage 3
1.2.5 Stage 4

Occurrence Rate of the Cervical Cancer
2.1 Incidence of the Cervical Cancer in Indian States
2.2 Prevalence of Cervical Cancer in India
2.3 Existence of the Cervical Cancer around the World

Risk Factors for Cervical Cancer
3.1 Reasons for High Cervical Cancer Frequencies
3.2 Rural v/s Urban Cervical Cancer Risk Trends

Cervical Cancer Screening in India
4.1 Accessible Screening Approaches in India
4.1.1 Pap smear Method
4.1.2 Liquid Based Cytology Method
4.1.3 Visual Inspection with the Acetic Acid (VIA)
4.1.4 HPV DNA Test
4.2 Screening for Cervical Cancer in Developing Countries
4.3 Cervical Cancer Screening Kits
4.3.1 VIRO-Safe Screening Kit
4.3.2 The Digene Hc2 High Risk HPV DNA Test Kit
4.3.3 Magnivisualizer Detecting Device


Therapeutics Strategies for the Treatment of Cervical Cancer
5.1 Surgery
5.1.1 Hysterectomy
5.1.2 Pelvic Exenteration
5.1.3 Radical hysterectomy
5.1.4 Conization
5.1.5 Trachelectomy
5.2 Radiotherapy
5.2.1 External Beam Radiation Therapy (EBRT)
5.2.2 Branchytherapy
5.3 Chemotherapy

HPV Vaccination in India
6.1 Introduction
6.2 Efficacy of the HPV Vaccine
6.3 Cost of HPV Vaccine for Developed and Developing Countries

Vaccination Programs by the Indian Government

Available HPV Vaccines in India
8.1 Quadrivalent Vaccine: - Gardasil
8.2 Bivalent Vaccine: - Cervarix

India Cervical Cancer Vaccines Market Analysis
9.1 India v/s Other Markets of Cervical Cancer Vaccine
9.2 Cervical Cancer Vaccine Market in India

HPV Vaccines Market Dynamics
10.1 Favorable Market Parameters
10.2 Challenges to the Development and Commercialization of HPV Vaccine

India Cervical Cancer Screening Market Future Prospects

Figure 1-1: Demonstration of Tumor Formation in Cervix
Figure 1-2: Cervical Cancer Stages
Figure 3-1: Factors for the Occurrence of Cervical Cancer
Figure 3-2: Burden of Cervical Cancer in India
Figure 4-1: Cervical Cancer Screening Approaches
Figure 4-2: India andndash; Market Opportunity for Pap Smear Test (US$ Billion), 2017 till 2022
Figure 4-3: India Market Opportunity for Pap Smear Test (INR Crore), 2017 till 2022
Figure 4-4: Visual Inspection with Acetic Acid Test Performance
Figure 4-5: Cervical Cancer Screening Programme Barriers
Figure 5-1: Treatment Approaches for Cervical Cancer
Figure 6-1: Market Price of HPV Vaccine in US and India (US$)
Figure 9-1: Segmentation of the Global Cervical Cancer Vaccine Market (%)
Figure 9-2: Three Regional Markets with the Growth Potential in World
Figure 9-3: India andndash; Market Opportunity for Cervarix and Gardasil Vaccine at Annual Dosage Rate (US$ Billion), 2017 till 2022
Figure 9-4: India andndash; Market Opportunity for Cervarix and Gardasil Vaccine at Annual Dosage Rate (INR Crore), 2017 till 2022
Figure 10-1: Favorable Market Drivers for the HPV Vaccine Market
Figure 10-2: Limiting Factors for the Cervical Cancer Market Growth

Table 2-1: Prevalence of Cervical Cancer in India
Table 4-1: Available Screening kits with the Market Price
Table 7-1: Challenges and the Solutions to the Project Implementation
Table 8-1: Bivalent and Quadrivalent HPV Vaccine

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.